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Ethanol administration has been shown to alter receptor-mediated endocytosis in the liver. We have developed a recombinant
hepatic cell line stably transfected with murine alcohol dehydrogenase cDNA to serve as an in vitro model to investigate these
ethanol-induced impairments. In the present study, transfected cells were maintained in the absence or presence of 25mM
ethanol for 7 days, and alterations in endocytosis by the asialoglycoprotein receptor were determined. The role of acetaldehyde
in this dysfunction was also examined by inclusion of the aldehyde dehydrogenase inhibitor, cyanamide. Our results showed that
ethanol metabolism impaired internalization of asialoorosomucoid, a ligand for the asialoglycoprotein receptor. The addition of
cyanamide potentiated the ethanol-induced defect in internalization and also impaired degradation of the ligand in the presence
of ethanol. These results indicate that the ethanol-induced impairment in endocytosis is exacerbated by the inhibition of aldehyde
dehydrogenase, suggesting the involvement of acetaldehyde in this dysfunction.
1.Introduction
Previous work from our laboratories has shown that etha-
nol administration impairs multiple aspects of the process
of receptor-mediated endocytosis (RME) in isolated hepato-
cytes[1–8].Decreasedbinding,internalization,anddegrada-
tion of two ligands known to be internalized by RME, asial-
oorosomucoid (ASOR) and epidermal growth factor (EGF),
have been described. These impairments appear to be due to
the metabolism, and not to the acute presence, of ethanol.
However, the direct involvement of ethanol metabolism in
these impairments has yet to be demonstrated. In order to
study these impairments in more detail, we have developed a
cell culture system. Using the diﬀerentiated hepatoblastoma
cell line Hep G2, which does not eﬃciently metabolize
ethanol, we have established a stably transfected cell line
that expresses alcohol dehydrogenase activity [9]. Hep G2
cells were chosen since previous work has shown that
the cells actively bind, internalize, and degrade ASOR by
RME in a similar fashion to that which is seen with rat
hepatocytes [10]. These cells, designated HAD (for having
alcohol dehydrogenase), have previously been shown to
metabolize ethanol eﬃciently and produce physiological
amounts of acetaldehyde. In addition, impaired binding of
theligand,ASOR,totheasialoglycoproteinreceptorhasbeen
demonstrated in these cells after chronic incubation with
ethanol [11]. The impaired ligand binding was alleviated
by the addition of pyrazole (an alcohol dehydrogenase in-
hibitor). These results indicated that the impairment in
bindingofASORwasdependentontheoxidation ofethanol,
providing very strong evidence for a requirement of ethanol
metabolisminthisdysfunction.Inthecurrentstudy,wehave
further characterized the impaired RME by investigating the
eﬀectsof7daysofethanoladministrationoninternalization,
degradation, and binding of ASOR in HAD cells. We also
incubated cells in the presence of ethanol and cyanamide (an
aldehyde dehydrogenase inhibitor), to increase steady-state
levels of acetaldehyde in the cultures in order to examine the
involvement of acetaldehyde in the impairments.2 International Journal of Hepatology
2.MaterialsandMethods
2.1. Establishment of Recombinant HAD Cells. HepG2 cells
were stably transfected with pIC-14, an eukaryotic expres-
sion plasmid containing a cDNA copy of the murine alcohol
dehydrogenase gene Adh-1 as described in a previous paper
[9].
2.2.CellsandCultureConditions. HepG2cells[12]wer ecul-
t u r e di nD u l b e c c o ’ sm o d i ﬁ e dE a g l e ’ sm e d i u m( D M E M )c o n -
taining high glucose supplemented with 2mM L-glutamine,
10% fetal bovine serum, and 50ug/mL gentamicin. Recom-
binant HAD cells were cultured in the same medium con-
taining 200ug/mL hygromycin B. All cells were cultured at
37◦C for 7 days in a humidiﬁed environment containing
5% CO2. During ethanol and acetaldehyde metabolism
studies, the growth media were supplemented with 25mM
ethanol or 0.1mM cyanamide (or both) and were culture in
sealed 25cm2 ﬂasks to minimize evaporation of ethanol and
acetaldehyde.
2.3. Binding of ASOR and Antiasialoglycoprotein Receptor
(ASGP-R) Antibody to Intact Cells. Cells were removed from
the plates with Eagle’s medium containing 2mM EDTA and
washed twice with Eagle’s/0.1%BSA before binding exper-
iments were initiated. (A) Ligand binding was performed
for 3 hours at 4◦C in the presence of 2ug/mL 125I-ASOR.
After the 3 hours, cells were washed 4-5 times with Eagle’s
medium, and amounts of radioactive ligand bound were
determined. Nonspeciﬁc binding (less than 10% of speciﬁc
binding) was determined in the presence of 100-fold excess
unlabeled ligand. (B) Antibody binding was also performed
at 4◦C, but in this case, the cells were incubated with primary
antibody (1:100 ﬁnal dilution) for 1 hour, washed, and
then incubated with 125I-protein A for 1 hour [8]. Cells
were then washed, and radioactivity associated with the cells
was determined. Nonspeciﬁc binding was determined in the
presence of nonimmune serum.
2.4. Internalization and Degradation of ASOR. Internaliza-
tion and degradation of 125I-ASOR was determined over a
time course of 5 hours. 125I-ASOR was added to cell cultures
at a ﬁnal concentration of 2ug/mL, and at the indicated
times, the ﬂasks were placed on ice and the cells removed
from the plate by the addition of 2mM EDTA to the wells.
Degradation products in the media were determined by
the presence of acid-soluble radioactivity, while internalized
ligand was represented by radioactivity in the cell pellet.
2.5. General. Results are expressed as fmoles ASOR bound,
internalized or degraded per million cells. A normalized
value of 11ug DNA per million cells was used for these
calculations [9]. Statistical analysis was determined using the
Student’s t test. A probability of 0.05 or less was considered
signiﬁcant.
3. Results
Initially,weexaminedtheabilityoftheligand,ASOR,tobind
to the ASGP-R after culturing HAD cells in the presence of
25mM ethanol for 7 days either in the presence or absence
of the aldehyde dehydrogenase inhibitor, cyanamide. These
data are shown in Figure 1. The addition of ethanol alone to
the growth media did not result in changes in ASOR bind-
ing. In the presence of cyanamide, which increases acetalde-
hyde concentrations to uM levels in these cells [9], the bind-
ing was signiﬁcantly impaired by 55% (Figure 1(a)). These
data show that there was no measurable impairment in
ligand binding in the presence of ethanol alone in this series
of experiments, but that during ethanol metabolism and in-
hibition of aldehyde dehydrogenase activity ligand binding
was signiﬁcantly decreased. Monitoring acetaldehyde levels
revealed that acetaldehyde levels in cells cultured in the pre-
senceofethanolandcyanamidepeakedatapproximately150
uM at 36 hours and then gradually declined.
We next examined the ability of a polyclonal antibody
against human ASGP-R to bind to the cells under these ex-
perimental conditions. No diﬀerences in antibody binding
were seen in the HAD cell populations, regardless of treat-
ment conditions (Figure 1(b)). Thus, the levels of the recep-
tor protein are unchanged in these cultures. The data presen-
ted here, along with that from Figure 1(a), indicate an
inactivation of the receptor as a result of acetaldehyde-in-
duced inhibition of ligand binding in the ethanol-treated
cultures containing cyanamide (a powerful inhibitor of alde-
hyde dehydrogenase). This inactivation phenomenon is sim-
ilar to that observed in rat hepatocytes after ethanol admin-
istration for 1-2 weeks [8].
We also examined the eﬀects of ethanol oxidation on the
ability of the asialoglycoprotein receptor to internalize lig-
and. The results indicated that internalization of ASOR was
signiﬁcantly impaired early in the time course of internal-
ization (the ﬁrst 150min, Figure 2(a)), and that the addi-
tion of cyanamide further potentiated this impairment
(Figure 2(b)). Since cyanamide alone (in the absence of
ethanol) did not alter internalization of ASOR, the results
implicate a role for acetaldehyde in the impaired internaliza-
tion in these cells.
We also investigated the degradation of ASOR in these
cell populations. In the presence of ethanol alone, degrada-
tion of ligand was unaltered over the 150min time course
of the experiment (Figure 3(a)). However, in the presence of
cyanamide in the culture medium, the degradation was de-
creased over the 5-hour course (Figure 3(b)). Again, these
dataimplicatethedirectinvolvementofacetaldehydeinthese
dysfunctions and further support the suggestion that aceta-
ldehyde mediates many of the impairments associated with
ethanol-induced hepatic cytotoxicity.
4. Discussion
We have previously reported the establishment of a recom-
binant hepatic cell line (HAD) that stably expresses alcohol
dehydrogenase and oxidizes ethanol to acetaldehyde. During
ethanol metabolism, ligand binding to the ASGP-R wasInternational Journal of Hepatology 3
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Figure 1: (a) Eﬀects of ethanol (25mM) and cyanamide (0.1mM) on binding of 125I-ASOR to HAD cells treated for 7 days. HAD cells were
grown to conﬂuence and treated as described in Section 2. Ligand binding was performed at 4◦C for 3 hours and non-speciﬁc binding was
determined in the presence of 100-fold excess unlabeled ligand. Data are presented as means ± SEM for 6–10 sets of cells. Legends: control:
HAD cells cultured in the absence of added ethanol; ethanol: HAD cells cultured in the presence of 25mM ethanol. Values signiﬁcantly
diﬀerent from controls are indicated,
∗P<0.05. (b) Eﬀects of ethanol administration (25mM) and cyanamide (0.1mM) on binding of
anti-ASGP-R antibody to HAD cells. Cell cultures were obtained from the same conditions as in Figure 1(a). Binding of antibody was
determined by the ability of cells to bind a polyclonal antihuman ASGP-receptor antibody, followed by radiolabeled detection of 125I-protein
A. Data are presented as means ± SEM for 6–10 experiments. Legends: control: HAD cells cultured in the absence of added ethanol; ethanol:
HAD cells cultured in the presence of 25mM ethanol.
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Figure 2: Kinetics of internalization (a) and degradation (b) of 125I-ASOR in HAD cells after 7 days of treatment with 25mM ethanol. Cells
weretreatedwith()orwithout()ethanolfor7daysaspreviouslydescribed.Attheendofthetreatmentperiod,cellswereincubatedwith
Eagles medium containing 1% BSA and 2ug per mL iodinated ASOR. At the indicated times, duplicate plates were removed from the 37◦C
incubator, the cells were removed from the plates with 2mM EDTA, and internalization (pellet associated, a) and degradation (acid-soluble
media radioactivity, b) were determined. Data are presented as fmoles internalized or degraded per million cells and are means ± SEM for
6–10 experiments. Values signiﬁcantly diﬀerent from controls are indicated,
∗P<0.05.4 International Journal of Hepatology
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Figure 3:Eﬀectsofcyanamideonkineticsofinternalization(a)anddegradation(b)of 125I-ASORinHADcellculturesgrowninthepresence
()o ra b s e n c e( ) of 25mM ethanol. Internalization (a) and degradation (b) of ASOR were determined as described in Figure 3.D a t aa r e
presented as fmoles ASOR degraded or internalized per million cells and are means ± SEM for 4-5 separate experiments. Values signiﬁcantly
diﬀerent from controls are indicated,
∗P<0.05.
shown to be decreased, and the impairment was alleviated
upon the addition of an alcohol dehydrogenase inhibitor,
pyrazole. These results suggested that ethanol metabolism
was necessary for the observed impairments in ligand
binding.Datapresentedinthisstudydemonstratethatafter7
days of ethanol exposure in HAD cells, ligand internalization
is also impaired. These impairments were most apparent
in the early times of internalization of the ligand. Upon
addition of cyanamide, an aldehyde dehydrogenase inhibitor
known to increase acetaldehyde levels in cells actively metab-
olizing ethanol, the impairments in internalization of ASOR
were potentiated dramatically. In addition, degradation of
ASOR and binding to its receptor were both signiﬁcantly
decreased when the cells were incubated with ethanol and
cyanamide, but not with ethanol alone. The presence of
cyanamide alone, in the absence of ethanol, did not alter
any aspect of endocytosis tested. Additionally, we have
demonstrated that higher levels of acetaldehyde increase the
severityofotherethanol-metabolism-mediatedimpairments
[13].Takentogetherthesedatafromthepresent studyaswell
aspreviousdataimplicateanimportantroleforacetaldehyde
in the ethanol-induced impairments in endocytosis in HAD
cells.
These ﬁndings are important and relevant to our under-
standing and examination of ethanol-induced alterations in
protein traﬃcking in the liver. It has been suggested that
the production of acetaldehyde may be responsible for some
of the hepatic impairments attributed to the oxidation of
ethanol [14, 15], and the formation of acetaldehyde-protein
adductscouldbe themechanism by whichalcoholultimately
damages cells [16, 17]. Although acetaldehyde is strongly
implicated as a mediator of the ethanol-induced dysfunction
in hepatic protein secretion, the role of acetaldehyde in im-
paired RME and signal transduction has not been es-
tablished. In addition, this has been diﬃcult to examine
mechanisticallyinaculturesystem,sincetheabilityofhepat-
ocytes to eﬃciently metabolize ethanol, as well as many
other liver-speciﬁc functions, are rapidly lost in culture [18].
The development of a hepatic cell line which is capable of
oxidizing ethanol, along with results presented in this study
showing a direct involvement of acetaldehyde in ethanol-
impaired RME in these cells, allows a diﬀerentiation between
the hepatotoxic eﬀects of ethanol itself and its oxidation pro-
ducts.Thisistheﬁrstreportforadirecteﬀectofacetaldehyde
on a continuous endocytic process, such as internalization
anddegradationofligandsbyRME.Theresultsofthesestud-
ies should aid in an examination of the hypothesis that the
production of acetaldehyde and its presence in the cell could
lead to the formation of acetaldehyde-protein adducts and
through their accumulation eventually cause hepatic dys-
function.
In conclusion, these studies show a direct involvement
for ethanol metabolism and subsequent acetaldehyde pro-
duction during the impaired receptor-mediated endocytosis
which occurs after ethanol administration. Use of the HAD
cells allows us to have the ability to examine the mechani-
sm(s) which are responsible for the ethanol-induced impair-
ments in liver cell function, which we feel are related to the
progression of alcoholic liver injury. Future work with the
HAD cells will aid in the elucidation of ethanol’s eﬀects onInternational Journal of Hepatology 5
altered endocytosis, signalling events, and protein traﬃcking
events in the liver. In addition, we can now examine the role
of acetaldehyde in the impairments.
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